GLP-1 Drugs

Viking Therapeutics Stock Could Soar 45% Ahead Of Key Weight Loss Drug Readout: JPMorgan

Bernie Sanders: 'Ozempic Will Likely Become One Of The Best-Selling Pharmaceutical Products In History' — Americans Shouldn't Pay 10-15X More

New Weight Loss ETF Is Essentially A Play On Eli Lilly, Novo Nordisk

Bernie Sanders: 'Ozempic Will Likely Become One Of The Best-Selling Pharmaceutical Products In History' — Americans Shouldn't Pay 10-15X More

New Weight Loss ETF Is Essentially A Play On Eli Lilly, Novo Nordisk

Mangoceuticals Develops Oral GLP-1s: Stock Soars

Two Big Upside Risks To Watch

Mangoceuticals Develops Oral GLP-1s: Stock Soars

Two Big Upside Risks To Watch

Goldman Sachs: Eli Lilly's Shares May Surge By 140% With GLP-1 Drug Boom

Bernie Sanders To Take On Ozempic, Wegovy, Weight Loss Drugs: 'Could Be Helpful, But They're Not Going To Be Helpful If People Can't Afford Them'

GLP-1 Drugs Recent News

Jim Cramer Highlights 'Transformational' Impact Of Weight Loss Drugs Like Ozempic: Focus Now On 'Potential Winners' From The Same Narrative

140,000 American Lives At Risk -- And This Drug Could Save Them

A new study could save hundreds of thousands of lives in the United States each year.

Want To Lose 10 Pounds? 'Miracle' Weight Loss Drugs Create Winners And Losers

Ozempic, Wegovy and Mounjaro could very well have become the most sought-after weight-loss drugs of the past two years, as press reports and social media amplification help push these new medications as a new "miracle treatment" for weight management. A February analysis by Jefferies puts sales of GLP-1 drugs for obesity above $100 billion by 2031.